Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Quality of life assessment in male patients with androgenetic alopecia: result of a prospective, multicenter study.

Han SH, Byun JW, Lee WS, Kang H, Kye YC, Kim KH, Kim DW, Kim MB, Kim SJ, Kim HO, Sim WY, Yoon TY, Huh CH, Hwang SS, Ro BI, Choi GS.

Ann Dermatol. 2012 Aug;24(3):311-8. doi: 10.5021/ad.2012.24.3.311. Epub 2012 Jul 25.

2.

Androgenetic Alopecia: Quality-of-life and Associated Lifestyle Patterns.

Sawant N, Chikhalkar S, Mehta V, Ravi M, Madke B, Khopkar U.

Int J Trichology. 2010 Jul;2(2):81-5. doi: 10.4103/0974-7753.77510.

3.

Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia.

Reid EE, Haley AC, Borovicka JH, Rademaker A, West DP, Colavincenzo M, Wickless H.

J Am Acad Dermatol. 2012 Mar;66(3):e97-102. doi: 10.1016/j.jaad.2010.11.042. Epub 2011 May 24.

PMID:
21601948
4.

Quality of life assessment in patients with alopecia areata and androgenetic alopecia in the People's Republic of China.

Zhang M, Zhang N.

Patient Prefer Adherence. 2017 Jan 27;11:151-155. doi: 10.2147/PPA.S121218. eCollection 2017.

5.

A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.

Olsen EA, Dunlap FE, Funicella T, Koperski JA, Swinehart JM, Tschen EH, Trancik RJ.

J Am Acad Dermatol. 2002 Sep;47(3):377-85.

PMID:
12196747
6.

Health-related quality of life and physical well-being among a 63-year-old cohort of women with androgenetic alopecia; a Finnish population-based study.

Hirsso P, Rajala U, Laakso M, Hiltunen L, Härkönen P, Keinänen-Kiukaanniemi S.

Health Qual Life Outcomes. 2005 Aug 24;3:49.

7.

Androgenetic alopecia: does its presence change our perceptions?

Karaman GC, Dereboy C, Dereboy F, Carman E.

Int J Dermatol. 2006 May;45(5):565-8.

PMID:
16700793
8.

Current understanding of androgenetic alopecia. Part II: clinical aspects and treatment.

Hoffmann R, Happle R.

Eur J Dermatol. 2000 Jul-Aug;10(5):410-7. Review.

PMID:
10882953
9.

Hair loss, insulin resistance, and heredity in middle-aged women. A population-based study.

Matilainen V, Laakso M, Hirsso P, Koskela P, Rajala U, Keinänen-Kiukaanniemi S.

J Cardiovasc Risk. 2003 Jun;10(3):227-31.

PMID:
12775957
10.

Guidelines for management of androgenetic alopecia based on BASP classification--the Asian Consensus Committee guideline.

Lee WS, Lee HJ, Choi GS, Cheong WK, Chow SK, Gabriel MT, Hau KL, Kang H, Mallari MR, Tsai RY, Zhang J, Zheng M.

J Eur Acad Dermatol Venereol. 2013 Aug;27(8):1026-34. doi: 10.1111/jdv.12034. Epub 2012 Nov 23.

PMID:
23176122
11.

Characteristics of androgenetic alopecia in asian.

Lee WS, Lee HJ.

Ann Dermatol. 2012 Aug;24(3):243-52. doi: 10.5021/ad.2012.24.3.243. Epub 2012 Jul 25.

12.
13.

The prevalence and types of androgenetic alopecia in Korean men and women.

Paik JH, Yoon JB, Sim WY, Kim BS, Kim NI.

Br J Dermatol. 2001 Jul;145(1):95-9.

PMID:
11453914
14.

Development of a health-related quality of life questionnaire for women with androgenetic alopecia.

Dolte KS, Girman CJ, Hartmaier S, Roberts J, Bergfeld W, Waldstreicher J.

Clin Exp Dermatol. 2000 Nov;25(8):637-42.

PMID:
11167980
15.

Early onset of androgenetic alopecia associated with early severe coronary heart disease: a population-based, case-control study.

Matilainen VA, Mäkinen PK, Keinänen-Kiukaanniemi SM.

J Cardiovasc Risk. 2001 Jun;8(3):147-51.

PMID:
11455846
16.

Management of androgenetic alopecia.

Tosti A, Camacho-Martinez F, Dawber R.

J Eur Acad Dermatol Venereol. 1999 May;12(3):205-14. Review.

PMID:
10461639
17.

Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study.

Arias-Santiago S, Gutiérrez-Salmerón MT, Castellote-Caballero L, Buendía-Eisman A, Naranjo-Sintes R.

J Am Acad Dermatol. 2010 Sep;63(3):420-9. doi: 10.1016/j.jaad.2009.10.018. Epub 2010 Jul 8.

PMID:
20619491
18.

Male pattern androgenetic alopecia in an Indian context: a perspective study.

Sehgal VN, Kak R, Aggarwal A, Srivastava G, Rajput P.

J Eur Acad Dermatol Venereol. 2007 Apr;21(4):473-9.

PMID:
17373973
19.

Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors.

Severi G, Sinclair R, Hopper JL, English DR, McCredie MR, Boyle P, Giles GG.

Br J Dermatol. 2003 Dec;149(6):1207-13.

PMID:
14674898
20.

Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.

Price VH, Roberts JL, Hordinsky M, Olsen EA, Savin R, Bergfeld W, Fiedler V, Lucky A, Whiting DA, Pappas F, Culbertson J, Kotey P, Meehan A, Waldstreicher J.

J Am Acad Dermatol. 2000 Nov;43(5 Pt 1):768-76.

PMID:
11050579

Supplemental Content

Support Center